Gerald Lee, MD; Stanley Fineman, MD, Merin Kalangara, MD
To download the mp3 file, right click on the player and select Save audio as.
Show Notes
For today’s episode we will be reviewing articles from the May-June 2019 issue of Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.
To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles!
Articles Reviewed:
- Reslizumab Compared with Benralizumab in Patients with Eosinophilic Asthma: A Systematic Literature Review and Network Meta-Analysis.
- Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison.
- Indirect Treatment Comparisons and Biologics
- Endotypes of severe allergic asthma patients who clinically benefit from anti?IgE therapy
- Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma
ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced.